Urgent.News

What's breaking now, across thousands of outlets.

AI

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

We haven't written up this one. Decrypt has the full story — the link below goes straight to it.

Read the original at decrypt.co →

More in AI

More from Tuesday 20 October →